155 related articles for article (PubMed ID: 10534293)
1. Pharmacotherapy of dyslipidemia in postmenopausal women: weighing the evidence.
Brophy DF; Crouch MA; Ruffin DM; Wazny LD; McKenney JM
J Womens Health Gend Based Med; 1999 Sep; 8(7):901-17. PubMed ID: 10534293
[TBL] [Abstract][Full Text] [Related]
2. The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women.
Seed M
Atheroscler Suppl; 2002 May; 3(1):53-63. PubMed ID: 12044587
[TBL] [Abstract][Full Text] [Related]
3. Primary prevention of coronary heart disease in women.
Rees M; Stevenson J;
Menopause Int; 2008 Mar; 14(1):40-5. PubMed ID: 18380961
[TBL] [Abstract][Full Text] [Related]
4. Emerging selective estrogen receptor modulators: special focus on effects on coronary heart disease in postmenopausal women.
Vogelvang TE; van der Mooren MJ; Mijatovic V; Kenemans P
Drugs; 2006; 66(2):191-221. PubMed ID: 16451093
[TBL] [Abstract][Full Text] [Related]
5. Management of hyperlipidemia in the elderly population: an evidence-based approach.
Dalal D; Robbins JA
South Med J; 2002 Nov; 95(11):1255-61. PubMed ID: 12539990
[TBL] [Abstract][Full Text] [Related]
6. A novel concept to preserve the beneficial effects of hormone replacement therapy in bilaterally female ovariectomized rats: role of lovastatin therapy.
El-Swefy SE; Asker ME; Ali SI; Mohammed HE
Pharmacol Res; 2002 Mar; 45(3):167-73. PubMed ID: 11884211
[TBL] [Abstract][Full Text] [Related]
7. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
Mobasseri S; Liebson PR; Klein LW
Cardiol Rev; 2004; 12(6):287-98. PubMed ID: 15476565
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesis.
Hodis HN; Mack WJ
J Steroid Biochem Mol Biol; 2014 Jul; 142():68-75. PubMed ID: 23851166
[TBL] [Abstract][Full Text] [Related]
9. Lipid-lowering therapy and the patient with multiple risk factors: what have we learned from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)?
Sever PS
Am J Med; 2005 Dec; 118 Suppl 12A():3-9. PubMed ID: 16356801
[TBL] [Abstract][Full Text] [Related]
10. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
Contreras I; Parra D
Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
[TBL] [Abstract][Full Text] [Related]
12. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular effects of estrogen in postmenopausal women].
Zhu WL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):409-12. PubMed ID: 12905664
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and coronary heart disease in women: a review of the evidence.
Low AK; Russell LD; Holman HE; Shepherd JM; Hicks GS; Brown CA
Am J Med Sci; 2002 Oct; 324(4):180-4. PubMed ID: 12385489
[TBL] [Abstract][Full Text] [Related]
15. Coronary heart disease and hormone replacement therapy after the menopause.
Hodis HN; Mack WJ
Climacteric; 2009; 12 Suppl 1():71-5. PubMed ID: 19811246
[TBL] [Abstract][Full Text] [Related]
16. Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma.
Diamanti-Kandarakis E; Sykiotis GP; Papavassiliou AG
Cancer; 2003 Jan; 97(1):12-20. PubMed ID: 12491500
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure control and hormone replacement therapy in postmenopausal women at risk for coronary heart disease.
McCubbin JA; Helfer SG; Switzer FS; Price TM
Am Heart J; 2002 Apr; 143(4):711-7. PubMed ID: 11923810
[TBL] [Abstract][Full Text] [Related]
18. Vascular effects of aromatase inhibitors: data from clinical trials.
Howell A; Cuzick J
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):143-9. PubMed ID: 15936188
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and cardiovascular disease revisited.
Stevenson JC
Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
[TBL] [Abstract][Full Text] [Related]
20. Estrogen plus progestin and the risk of coronary heart disease.
Manson JE; Hsia J; Johnson KC; Rossouw JE; Assaf AR; Lasser NL; Trevisan M; Black HR; Heckbert SR; Detrano R; Strickland OL; Wong ND; Crouse JR; Stein E; Cushman M;
N Engl J Med; 2003 Aug; 349(6):523-34. PubMed ID: 12904517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
